Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fortis Life Sciences is a strategic platform company founded in 2020 to provide capital, expertise, and operational resources to founder-led life science tools companies. Backed by Summit Partners, the company has built a diverse portfolio of high-quality brands serving the diagnostic, therapeutic, and research markets. Its subsidiaries include Bethyl Laboratories (antibodies), nanoComposix (nanomaterials), Empirical Bioscience (enzymes), Arista Biologicals (reagents), and Abcore (antibody discovery). Fortis focuses on scaling these businesses by enhancing their commercial, operational, and technical infrastructure to accelerate growth and innovation in the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fortis Private Equity.